Form 4: Neurocrine Biosciences CEO Receives Stock Grant
Insider Transaction (Form 4)
Kyle Gano, Chief Executive Officer and a Director of Neurocrine Biosciences Inc, reported multiple transactions in common stock on September 11, 2026.
Summary
- Grant/award: acquired 6,275 Common Stock on September 11, 2026; holds 157,266 after (Direct).
- Tax/exercise-price withholding: disposed of 3,386 Common Stock at $156.22 ($528,961) on September 11, 2026; holds 153,880 after (Direct).
- Grant/award: acquired 1,842 Common Stock on September 11, 2026; holds 155,722 after (Direct).
- Tax/exercise-price withholding: disposed of 994 Common Stock at $156.22 ($155,283) on September 11, 2026; holds 154,728 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kyle Gano — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Grant/award | Common Stock | 6,275 | — | — | 157,266 |
| 2026-09-11 | Tax/exercise-price withholding | Common Stock | 3,386 | $156 | $529.0K | 153,880 |
| 2026-09-11 | Grant/award | Common Stock | 1,842 | — | — | 155,722 |
| 2026-09-11 | Tax/exercise-price withholding | Common Stock | 994 | $156 | $155.3K | 154,728 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Grant/award (6,275 shares) |
| 2026-09-11 | Tax/exercise-price withholding (3,386 shares) |
| 2026-09-11 | Grant/award (1,842 shares) |
| 2026-09-11 | Tax/exercise-price withholding (994 shares) |
Keywords
insider transaction, Form 4, NBIX, NEUROCRINE BIOSCIENCES INC, neutral, Kyle Gano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.